Table 3.
Percentages of specific targets lysis by HLA-A2+ effec-tor CTLs induced by PBMCs from healthy donors with differ-ent peptide antigens (mean ± SD, n = 27)
| E/T ratios |
Percentage of specific cell lysis (%) |
||||
| Peptide1d | Peptide2d | Peptide3db | Irrelevant controla | Negative controls | |
| 12.5 | 22.7 ± 5.3 | 21.7 ± 6.1 | 36.1 ± 7.7 | 3.7 ± 0.7 | 3.5 ± 0.7 |
| 25 | 29.3 ± 6.5 | 28.6 ± 6.3 | 41.4 ± 9.1 | 5.7 ± 0.7 | 3.7 ± 0.7 |
| 50 | 33.5 ± 7.1 | 33.9 ± 8.2 | 52.3 ± 12.5 | 7.3 ± 0.9 | 6.4 ± 0.9 |
| 100 | 37.2 ± 11.2 | 36.8 ± 10.9 | 68.4 ± 14.7 | 7.4 ± 1.1 | 8.7 ± 1.3 |
P > 0.05 vs negative control,
P < 0.01 vs peptide1 and 2 groups,
P < 0.01 vs negative control.